Trial Profile
Quetiapine versus sertraline as the pharmacological component in a standardised psychopharmacological and psychotherapeutic treatment of borderline personality disorder: a randomised, rater-blinded study
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 17 Mar 2009
Price :
$35
*
At a glance
- Drugs Quetiapine (Primary) ; Sertraline (Primary)
- Indications Borderline personality disorders
- Focus Therapeutic Use
- Acronyms QuBor
- 15 Mar 2009 Status changed from active, no longer recruiting to completed, according to ISRCTN: Current Controlled Trials.
- 23 Oct 2006 Status change
- 22 Oct 2006 New trial record.